NCCN Standard of Care Guidelines are updated each year with new biomarkers and associated CDx treatment options for all types of cancers. By the end of 2020 non-small cell lung cancer will have 9 molecular biomarkers to test for standard of care. Join us for this event to learn and discuss how in-house Next Generation Sequencing (NGS) and precision medicine programs can improve patient care and help your organization meet ever-evolving guidelines. CE Credits are available for this event. This event is open to all registrants.

By the conclusion of this session you will understand:

• 2020 standard of care changes in clinical oncology and limitations with current testing technology
• Lab and administrative factors to consider when bringing NGS in-house
• Oncologist needs in the precision medicine space and how you can work with them to drive the best outcomes for patients

Learning Objectives:

     1. Review the benefits of next generation sequencing testing for pathologists

     2. Summarize the potential improvements to patient care based on bringing next

         generation sequencing in-house

This virtual meeting will be conducted within OncomineWorld in our virtual auditorium. OncomineWorld is so much more than your traditional virtual event – you can navigate to many different areas and experience a new level of virtual interactivity. Within OncomineWorld you can…

• Explore the NGS Oncology Application Hall and its many specialty booth-labs including immuno-oncology research, emerging NSCLC biomarkers, liquid biopsy, PIK3Ca research testing, and hemato-oncology research
• Visit our virtual lab to experience the new world of easy and fast NGS - the Ion Torrent Genexus System - and become familiar with our well-proven workhorse, the Ion Torrent GeneStudio system, with its many applications
• Earn continuing education (CE) credits by listening to 12 educational talks from leading NGS users on topics such as comprehensive genomic profiling (CGP), the future of precision oncology biomarkers testing in the routine clinical space, personal experiences with different NGS products and solutions, and much more
• Visit the Precision Oncology Hall to access videos, posters and more on the future potential of NGS in the clinic
• See the latest research by Thermo Fisher Scientific in the Poster Hall